This document summarizes a study that used CRISPR/Cas9 to knockout the elovl2 gene in Atlantic salmon in order to increase their omega-3 fatty acid content. The researchers found that elovl2 knockout inhibited the elongation of polyunsaturated fatty acids like EPA and DHA, leading to higher levels of shorter chain omega-3s. This inhibition also induced the expression of hepatic genes related to lipogenesis. The study demonstrates the key role of elovl2 in salmon fatty acid biosynthesis and suggests its potential as a selective breeding marker to increase the conversion of plant oils to EPA/DHA for aquaculture and human nutrition.